2017
DOI: 10.25164/cnr201701005
|View full text |Cite
|
Sign up to set email alerts
|

Changing trends and influencing factors of the quality of life of chemotherapy patients with breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
4
2
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(9 citation statements)
references
References 0 publications
2
4
2
1
Order By: Relevance
“…This finding is consistent with previous studies that found that patients who received multiple types of CTX reported more treatment-related adverse effects, which can negatively impact their QOL [29,30]. In addition, and consistent with our findings regarding length of time from cancer diagnosis, patients are more likely to receive additional treatments as a result of disease progression which could result in cumulative toxicities [31].…”
Section: Discussionsupporting
confidence: 93%
See 2 more Smart Citations
“…This finding is consistent with previous studies that found that patients who received multiple types of CTX reported more treatment-related adverse effects, which can negatively impact their QOL [29,30]. In addition, and consistent with our findings regarding length of time from cancer diagnosis, patients are more likely to receive additional treatments as a result of disease progression which could result in cumulative toxicities [31].…”
Section: Discussionsupporting
confidence: 93%
“…Descriptive statistics as means and standard deviations (SD) for quantitative variables and frequencies and percentages for categorical variables were calculated. Based on a review of the literature of characteristics that are known to influence the QOL of patients with cancer, treatment group (i.e., CTX alone or in combination with TT) [22,23], age [24,25], number of metastatic sites [26], time from cancer diagnosis [27,28], number of prior cancer treatments [29,30], GI cancer diagnosis [17], CTX regimen [31] were evaluated as covariates in our longitudinal analyses.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Esse tratamento consiste na administração de substâncias citotóxicas, principalmente por via sistêmica. Pacientes submetidos a esse tratamento podem apresentar efeitos colaterais como náuseas, vômitos, alterações de massa corporal e ansiedade, levando a mudanças na qualidade de vida 2,3 .…”
Section: Introductionunclassified
“…Finally, unaddressed physical symptoms and psychosocial challenges may lead to patients' compromised wellbeing such as decreased self-efficacy, increased risk of substance use, and reduced quality of life. For example, studies have found that breast cancer patients' quality of life was the lowest before postoperative chemotherapy, increased after the second chemotherapy, then lowered again after the fourth and fifth rounds of chemotherapy [18]. The quality of life trajectory among breast cancer patients continues to fluctuate throughout their post-treatment survivorship care, highlighting the needs for ongoing surveillance and interventions to address breast cancer patients' biopsychosocial challenges [19].…”
mentioning
confidence: 99%